The role of polymerase chain reaction of high-risk human papilloma virus in the screening of high-grade squamous intraepithelial lesions in the anal mucosa of human immunodeficiency virus-positive males having sex with males

Carmen Hidalgo-Tenorio, Mar Rivero-Rodriguez, Concepción Gil-Anguita, Javier Esquivias, Rodrigo López-Castro, Jessica Ramírez-Taboada, Mercedes López de Hierro, Miguel A López-Ruiz, R Javier Martínez, Juan P Llaño, Carmen Hidalgo-Tenorio, Mar Rivero-Rodriguez, Concepción Gil-Anguita, Javier Esquivias, Rodrigo López-Castro, Jessica Ramírez-Taboada, Mercedes López de Hierro, Miguel A López-Ruiz, R Javier Martínez, Juan P Llaño

Abstract

Objectives: To evaluate the advantages of cytology and PCR of high-risk human papilloma virus (PCR HR-HPV) infection in biopsy-derived diagnosis of high-grade squamous intraepithelial lesions (HSIL = AIN2/AIN3) in HIV-positive men having sex with men (MSM).

Methods: This is a single-centered study conducted between May 2010 and May 2014 in patients (n = 201, mean age 37 years) recruited from our outpatient clinic. Samples of anal canal mucosa were taken into liquid medium for PCR HPV analysis and for cytology. Anoscopy was performed for histology evaluation.

Results: Anoscopy showed 33.8% were normal, 47.8% low-grade squamous intraepithelial lesions (LSIL), and 18.4% HSIL; 80.2% had HR-HPV. PCR of HR-HPV had greater sensitivity than did cytology (88.8% vs. 75.7%) in HSIL screening, with similar positive (PPV) and negative predictive value (NPV) of 20.3 vs. 22.9 and 89.7 vs. 88.1, respectively. Combining both tests increased the sensitivity and NPV of HSIL diagnosis to 100%. Correlation of cytology vs. histology was, generally, very low and PCR of HR-HPV vs. histology was non-existent (<0.2) or low (<0.4). Area under the receiver operating characteristics (AUROC) curve analysis of cytology and PCR HR-HPV for the diagnosis of HSIL was poor (<0.6). Multivariate regression analysis showed protective factors against HSIL were: viral suppression (OR: 0.312; 95%CI: 0.099-0.984), and/or syphilis infection (OR: 0.193; 95%CI: 0.045-0.827). HSIL risk was associated with HPV-68 genotype (OR: 20.1; 95%CI: 2.04-197.82).

Conclusions: When cytology and PCR HR-HPV findings are normal, the diagnosis of pre-malignant HSIL can be reliably ruled-out in HIV suppression with treatment protects against the appearance of HSIL [corrected].

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Fig 1. ROC curve of HR-HPV-negative and…
Fig 1. ROC curve of HR-HPV-negative and normal cytology vs. normal histology.

References

    1. Kutlubay Z, Engin B, Zara T, Tüzün Y. Anogenital malignancies and premalignancies: facts and controversies. Clin Dermatol. 2013; 31: 362–373. 10.1016/j.clindermatol.2013.01.003
    1. Shiels MS, Cole SR, Kirk GD, Poole C. A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr. 2009; 52: 611–622. 10.1097/QAI.0b013e3181b327ca
    1. Ching- Hong PV, Palefsky JM. Natural History and Clinical Management of Anal Human Papillomavirus Disease in Men and Women Infected with Human Inmunodeficiency Virus. Clin Infect Dis. 2002; 35: 1127–1134.
    1. Salati SA, Al Kadi A (Anal cancer—a review. Int J Health Sci. 2012; 6: 206–230.
    1. Bosch FX, Manos MM, Munoz N, Sherman M, Jansen AM, Peto J, et al. Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. International biological study on cervical cancer (IBSCC) Study group. J Natl Cancer Inst. 1995; 87:796
    1. Garbuglia AR, Piselli P, Lapa D, Sias C, Del Nonno F, Baiocchini A et al. Frequency and multiplicity of human papillomavirus infection in HIV-1 positive women in Italy. J Clin Virol. 2012; 54: 141–146. 10.1016/j.jcv.2012.02.013
    1. Hidalgo-Tenorio C, Rivero Rodríguez M, Concha A, Gil Anguita C, López Castro R, López del Hierro M, et al. CD4 lymphocytes as a protective factor against infection by oncogenic genotypes of human papillomavirus in the anal mucosa of men who have sex with human immunodeficiency virus positive men. Med Clin (Barc). 2013; 140: 193–199. 10.1016/j.medcli.2012.05.044
    1. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008; 22: 1203–1211. 10.1097/QAD.0b013e3283023f78
    1. D'Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, et al. Incidence and epidemiology of anal cancer in the multicenter AIDS cohort study. Acquir Immune Defic Syndr. 2008; 48: 491–499. 10.1097/QAI.0b013e31817aebfe
    1. Diamond C, Taylor TH, Aboumrad T,Bringman D, Anton-Culver H. Increased incidence of squamous cell anal cancer among men with AIDS in the era of highly active antiretroviral therapy. Sex Transm Dis. 2005; 32: 314–320.
    1. Silverberg MJ, Lau B, Justice AC, Engels E, Gill MJ, Goedert JJ, et al. and North American AIDS Cohort Collaboration on Research and Design (NA-ACCORD) of IeDEA. Risk of anal cancer in HIV-infected and HIV-uninfected individuals in North America.Clin Infect Dis. 2012; 54: 1026–34. 10.1093/cid/cir1012
    1. Franceschi S, Lise M, Clifford GM, Rickenbach M, Levi F, Maspoli M, et al. Changing patterns of cancer incidence in the early- and late-HAART periods: the Swiss HIV Cohort Study. Br J Cancer 2010; 103: 416–422. 10.1038/sj.bjc.6605756
    1. Van Der Snoek EM, Van Der Ende ME, Den Hollander JC, Schutten M, Neumann HA, avn Doornum GJ. Use of highly active antiretroviral therapy is associated with lower prevalence of anal intraepithelial neoplastic lesions and lower prevalence of human papillomavirus in HIV-infected men who have sex with men. Sex Transm Dis. 2012; 39: 495–500. 10.1097/OLQ.0b013e31825aa764
    1. Hidalgo-Tenorio C, Rivero-Rodriguez M, Gil-Anguita C, Lopez De Hierro M, Palma P, Ramírez Taboada J, et al. (2014) Antiretroviral therapy as a factor protective against anal dysplasia in HIV-infected males who have sex with males. PLoS One. 2014; 27: e92376 eCollection 10.1371/journal.pone.0092376
    1. de Pokomandy A, Rouleau D, Ghattas G, Trottier H, Vézina S, Coté P, Macleod J, et al. HAART and progression to high-grade anal intraepithelial neoplasia in men who have sex with men and are infected with HIV. Clin Infect Dis. 2011; 52: 1174–1181. 10.1093/cid/cir064
    1. Goldie SJ, Kuntz KM, Weinstein MC, Freedber KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999; 281: 1822–1829.
    1. European AIDS Clinical Society. Guidelines. 2014: 28. (version 7.02). Available: .
    1. Aberg JA, Kaplan JE, Libman H, Emmanuel P, Anderson JR, Stone VE, et al. Primary care guidelines for the management of persons infected with human immunodeficiency virus: 2009 update by the HIV medicine Association of the Infectious Diseases Society of America. Clin Infec Dis. 2009; 49: 651–681. 10.1086/605292
    1. Panel de expertos del Grupo de Estudio de Sida (GESIDA). Guía de práctica clínica sobre los tumores no definitorios de SIDA e infección por el VIH. Jan 2014; Avalaible in: .
    1. Panther LA, Wagner K, Proper J, Fugelso DK, Chatis PA, Weeden W, et al. High resolution anoscopy findings for men who have sex with men: Inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infec Dis. 2004; 38: 1490–1492.
    1. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. Classification of papillomaviruses. Virology. 2004; 324:17–27.
    1. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, et al. The 2001 Bethesda system: terminology for reporting results of cervical cytology. JAMA. 2002; 287: 2114–2119.
    1. Darragh TM, Colgan TJ, Cox JT, Heller DS, Henry MR, Luff RD, et al. The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions: background and consensus recommendations from the College of American Pathologists and the American Society for Colposcopy and Cervical Pathology. J Low Genit Tract Dis. 2012; 16: 205–242.
    1. Andrés AM, Marzo PF. Chance-corrected measures of reliability and validity in K x K tables. Stat Methods Med Res. 2005; 14:473–492.
    1. Freeman DH. Applied categorical data analysis New York, USA, Marcel Dekker; 1987.
    1. Salit IE, Lytwyn A, Raboud J, Sano M, Chong S, Diong C, et al. The role of cytology (Pap test) and human papillomavirus testing in anal cancer screening. AIDS. 2001; 24: 1307–1313.
    1. Walts AE, Thomas P, Bose S. Anal cytology: is there a role for reflex HPV DNA testing? Diagn Cytopathol. 2005; 33: 152–156.
    1. Goldstone SE, Enyinna ChS, Davis TW. Detection of oncogenic human papillomavirus and other predictors of anal high-grade dysplasia in men who have sex with men with abnormal cytology. Dis Colon Rectum. 2009; 52: 31–39. 10.1007/DCR.0b013e31819736aa
    1. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV, et al. Performance characteristics of anal cytology and human paillomavirus testing in patients with high resolution anoscopy-guided biopsy of high grade anal intraepithelial neoplasia. Dis Colon Rectum. 2009; 52: 239–247. 10.1007/DCR.0b013e31819793d9
    1. Padilla-España L, Repiso-Jiménez B, Fernández-Sánchez F, Frieyro-Elicegui M, Fernández-Morano T, Pereda T, et al. (2014). Usefulness of human papillomavirus testing in anal intraepithelial neoplasia screening in a risk behaviour population. Enferm Infecc Microbiol Clin. 2014; 4. pii: S0213-005X(14)00136-0. doi:
    1. Chin-Hong PV, Berry JM, Cheng SC, Catania JA, Da Costa M, Darragh TM, et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med. 2008; 149: 300–306.
    1. Nathan M, Singh N. Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings. AIDS. 2010; 24: 373–379. 10.1097/QAD.0b013e328333ab8e
    1. Botes LP, Pett S, Carr A, Marriott D, Cooper DA, Matthews G, et al. Anal cytological abnormalities are poor predictors of high-grade intraepithelial neoplasia amongst HIV-positive men who have sex with men. Sex Health. 2013; 10: 9–17. 10.1071/SH11135
    1. Lam JM, Hoch JS, Tinmouth J, Sano M, Raboud J, Salit IE. Cost-effectiveness of screening for anal precancers in HIV-positive men. AIDS. 2011; 25: 635–642. 10.1097/QAD.0b013e3283434594
    1. Pinzone MR, Fiorica F, Di Rosa M, Malaguarnera G, Malaguarnera L, Cacopardo B, et al. Non-AIDS-defining cancers among HIV-infected people. Eur Rev Med Pharmacol Sci. 2012; 16: 1377–1388.
    1. Fraunhoiz IB, Harberl A, Klauke S, Gute P, Rodel CM. Long-term effects of chemotherapy for anal cancer in patients with HIV infection: oncological outcomes, immunological status, and the clinical course of HIV disease. Dis Colon Rectum. 2014; 57: 423–431. 10.1097/DCR.0000000000000057
    1. Weis SE. Current treatment options for management of anal intraepithelial neoplasia. Onco Targets and Therapy. 2013; 6: 651–665. 10.2147/OTT.S38217
    1. Machalek DA, Poynten M, Jin F, Fairley CK, Farnsworth A, Garland SM, et al. Anal human papillomavirus infection and associated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol. 2012; 13: 487–500. 10.1016/S1470-2045(12)70080-3
    1. Schim van der Loeff MF, Mooij SH, Richel O, de Vries HJ, Prins JM. HPV and anal cancer in HIV-infected individuals: A Review. Curr HIV/AIDS Rep.2014; Jul 3.
    1. Chan SY, Bernard HU, Ong CK, Chan SP, Hofmann B, Delius H. Phylogenetic analysis of 48 papillomavirus types and 28 subtypes and variants: a showcase for the molecular evolution of DNA viruses. J Virol. 1992; 66: 5714–5725.
    1. Darwich L, Videla S, Cañadas MP, Piñol M, García-Cuyàs F, Vela S, et al. Distribution of human papillomavirus genotypes in anal cytological and histological specimens from HIV-infected men who have sex with men and men who have sex with women. Dis Colon Rectum. 2013; 56:1043–1052 10.1097/DCR.0b013e31829c654f

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren